Other languages LumiraDx Limited

Equities

Market Closed - OTC Markets Other stock markets 03:36:11 2024-07-10 pm EDT			5-day change	1st Jan Change
0.0169 ^USD	+28.22%		+14.19%	-73.13%

May. 24	Roche, LumiraDx Deal Probed by U.K. Competition Watchdog	DJ
May. 20	U.K. Competition Watchdog Weighs Potential Impact of Roche-LumiraDx	DJ

Britische Wettbewerbsaufsicht CMA prüft Roche-LumiraDx-Deal	May. 24
CMA wägt mögliche Auswirkungen von Roche-LumiraDx-Deal ab	May. 20
Top Midday Decliners	Jan. 08
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data	Jan. 02
Top Premarket Decliners	Jan. 02
Roche to buy part of LumiraDx diagnostics platform for $295 million	Dec. 29
Wall Street Set to Open Lower Friday as Investors Await Economic Data, Powell Speech	Dec. 01
Investors Look Ahead to Powell Speech as US Futures Trend Lower Friday	Dec. 01
Top Premarket Decliners	Dec. 01
LumiraDx Limited Announces Resignation of Lu Huang from the Board of Directors	Nov. 07
LumiraDx Limited Announces Board Appointments	Nov. 06
LumiraDx Limited Appoints Veronique Ameye as the Company?s Chief Executive Officer and General Counsel, Effective as of November 1, 2023	Nov. 06
LumiraDx Limited Announces Board Resignations	Nov. 01
LumiraDx Limited Announces Resignation of Ron Zwanziger as Chief Executive Officer	Nov. 01
Wall Street Set to Open Lower Monday as National Activity Index Shows Near-Historic Economic Growth	23-10-23
LumiraDx to Partner With AstraZeneca, Everton Charity Arm For Heart And Lung Screening Hub	23-10-23
Investors Await Economic, Inflation Data as US Futures Trend Lower in Monday's Premarket	23-10-23
Top Premarket Gainers	23-10-23
LumiraDx Limited Announces Resignation of Gerald L. Chan from the Board of Directors	23-09-26
LumiraDx Limited Announces Executive Changes	23-08-24

No results for this search